NIH-funded research NIH-funded research

Investigating how unacylated ghrelin affects muscle weakness and loss in aging and cancer patients

Official title: The role of unacylated ghrelin on age-associated progressive muscle weakness and cachexia elicited by cancer

Funded at Wake Forest University Health Sciences · NIH-10791902 · Data updated 2026-11-12

This study is looking at how a hormone called unacylated ghrelin might help older adults and cancer patients keep their muscles strong and healthy, which could improve their overall quality of life.

More Cachexia research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWake Forest University Health Sciences
NIH-funded
Lab location1 site (Winston-Salem, United States)
Project startFebruary 15, 2020
Project endJanuary 31, 2026
Funding year2024
Award (this year)$249,000
NIH project number5R00AG064143-05
Project IDNIH-10791902 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who are experiencing muscle weakness or cachexia due to aging or cancer.

Less likely to help

Patients who are not experiencing muscle weakness or cachexia, or those under 21 years of age, may not benefit from this research.

What this research studies

This research focuses on the effects of unacylated ghrelin, a hormone, on preventing muscle weakness and loss associated with aging and cancer cachexia. The study aims to explore how this hormone can promote muscle health by enhancing muscle cell differentiation and reducing atrophy. Patients may benefit from a novel treatment that could improve their quality of life by maintaining muscle mass and strength. The research involves both laboratory experiments and potential clinical applications.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that help patients maintain muscle strength and mass, improving their overall health and quality of life.

How similar studies have gone: Previous studies have shown promising results with similar hormonal interventions, suggesting potential for success in this novel approach.

Where this research is happening

  • Wake Forest University Health Sciences
    Winston-Salem, United States
    Active

Researchers

  • Principal investigator: Ahn, Bumsoo — Wake Forest University Health Sciences
  • Study coordinator: Ahn, Bumsoo

Related research

Other NIH-funded projects on the same topics.

  • Investigating how unacylated ghrelin affects muscle weakness in aging and cancer.

    This study is looking at whether a hormone called unacylated ghrelin can help older adults and cancer patients keep their muscles strong and prevent muscle loss, with the hope of finding a new way to support those dealing with muscle weakness.

    NIH research Wake Forest University Health Sciences · Winston-Salem, United States · NIH-11017108

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • CANCAN: A Virtual Institute to Cure Cancer Cachexia

    A broad, collaborative NIH initiative aims to uncover why cancer patients lose weight and muscle and to develop new ways to treat this serious condition.

    NIH research New York University School of Medicine · New York, United States · NIH-11596283

  • Adipose tissue and its role in lung cancer cachexia

    A new NIH grant explores how fat tissue around the body may feed lung cancer growth and drive weight loss, with the aim of finding ways to help patients who struggle with cancer cachexia.

    NIH research University of Vermont & St Agric College · Burlington, United States · NIH-11587408

  • Spatial metabolism mapping in cancer cachexia tissues

    Aims to map where and how metabolism changes in tissues affected by cancer cachexia using advanced imaging technology.

    NIH research Northwestern University · Chicago, United States · NIH-11539627

  • Innate inflammatory control of cachexia in chronic disease

    A research team is studying how inflammation drives cachexia in chronic disease using a parasite model to find therapies that could protect lean body mass without raising infection risk.

    NIH research University of Virginia · Charlottesville, United States · NIH-11508215

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.